FDA — authorised 25 February 1977
- Status: approved
🇺🇸 Tavist in United States
FDA authorised Tavist on 25 February 1977
Marketing authorisations
FDA — authorised 25 February 1977
- Application: NDA017661
- Marketing authorisation holder: NOVARTIS
- Local brand name: TAVIST
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 26 January 1994
- Application: ANDA073283
- Marketing authorisation holder: GENUS
- Indication: Manufacturing (CMC)
- Status: approved
FDA — authorised 5 May 1997
- Application: ANDA073399
- Marketing authorisation holder: GENUS
- Indication: Manufacturing (CMC)
- Status: approved
FDA — authorised 17 December 1997
- Application: ANDA074884
- Marketing authorisation holder: NEW HEIGHTSRX
- Status: approved
Tavist in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Tavist approved in United States?
Yes. FDA authorised it on 25 February 1977; FDA authorised it on 25 February 1977; FDA authorised it on 26 January 1994.
Who is the marketing authorisation holder for Tavist in United States?
Marketing authorisation holder not available in our data.